Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Septic Patients Admitted to the ICU or the ED

NCT04470973 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04470973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04470973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Septic Patients Admitted to the ICU or the ED
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2020
Completion date
December 15, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill, infection, bacterial, sepsis, septic shock